Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits

OBJECTIVES: Value‐based pricing of oncology drugs provides a best estimate for the price of a drug, as it relates to the benefits it provides for individual patients. To date, the impact of value‐based pricing to reference cost‐effectiveness thresholds (λ) on individual and population‐level health b...

Descripción completa

Detalles Bibliográficos
Autores principales: Parmar, Ambica, Jiao, Tina, Saluja, Ronak, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943176/
https://www.ncbi.nlm.nih.gov/pubmed/31711274
http://dx.doi.org/10.1002/cam4.2694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943176/
https://www.ncbi.nlm.nih.gov/pubmed/31711274
http://dx.doi.org/10.1002/cam4.2694

Ejemplares similares